83 related articles for article (PubMed ID: 27609473)
21. Association of CASP3 genetic polymorphisms rs1049216, rs2705897 and rs4647603 with the risk of prostate cancer in Galicia (NW Spain).
López-Trigo N; Aguín N; Castuera IP; Rodríguez-Alonso A; Luis JR; Caeiro B
Gene; 2018 Dec; 679():126-132. PubMed ID: 30176316
[TBL] [Abstract][Full Text] [Related]
22. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
Safarinejad MR; Shafiei N; Safarinejad S
Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
[TBL] [Abstract][Full Text] [Related]
23. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer.
Mittal RD; Srivastava DL
DNA Cell Biol; 2007 Nov; 26(11):791-8. PubMed ID: 17919073
[TBL] [Abstract][Full Text] [Related]
25. Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancer.
Chang WS; Lin SS; Li FJ; Tsai CW; Li LY; Lien CS; Liao WL; Wu HC; Tsai CH; Shih TC; Bau DT
Anticancer Res; 2013 Nov; 33(11):4907-12. PubMed ID: 24222128
[TBL] [Abstract][Full Text] [Related]
26. Interleukin (IL)-8 polymorphisms and risk of prostate disorders.
Taheri M; Noroozi R; Dehghan A; Roozbahani GA; Omrani MD; Ghafouri-Fard S
Gene; 2019 Apr; 692():22-25. PubMed ID: 30641210
[TBL] [Abstract][Full Text] [Related]
27. Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.
Samzadeh M; Hasanzad M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaee SA
Urol J; 2012; 9(4):691-9. PubMed ID: 23235975
[TBL] [Abstract][Full Text] [Related]
28. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
[TBL] [Abstract][Full Text] [Related]
29. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
[TBL] [Abstract][Full Text] [Related]
30. Association between lncrna PCGEM1 polymorphisms and prostate cancer risk.
Xue Y; Wang M; Kang M; Wang Q; Wu B; Chu H; Zhong D; Qin C; Yin C; Zhang Z; Wu D
Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):139-44, S1. PubMed ID: 23459097
[TBL] [Abstract][Full Text] [Related]
31. Association between VHL single nucleotide polymorphism (rs779805) and the susceptibility to prostate cancer in Chinese.
Chen J; Wu Y; Shao P; Cao Q; Qin C; Li P; Ding Q; Zhu J; Wang M; Zhang Z; Li J; Yin C
DNA Cell Biol; 2012 May; 31(5):790-6. PubMed ID: 22084938
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
[TBL] [Abstract][Full Text] [Related]
33. Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer.
Khooshemehri P; Jamaldini SH; Ziaee SAM; Afshari M; Sattari M; Narouie B; Sotoudeh M; Montazeri V; Sarhangi N; Hasanzad M
Urol J; 2020 May; 17(3):271-275. PubMed ID: 31953835
[TBL] [Abstract][Full Text] [Related]
34. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
[TBL] [Abstract][Full Text] [Related]
35. Association of IL-1β and IL-10 Polymorphisms with Prostate Cancer Risk and Grade of Disease in Eastern Croatian Population.
Horvat V; Mandić S; Marczi S; Mrčela M; Galić J
Coll Antropol; 2015 Jun; 39(2):393-400. PubMed ID: 26753456
[TBL] [Abstract][Full Text] [Related]
36. Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer.
Antognelli C; Mearini L; Talesa VN; Giannantoni A; Mearini E
Prostate; 2005 May; 63(3):240-51. PubMed ID: 15538743
[TBL] [Abstract][Full Text] [Related]
37. Human glutathione S-transferase polymorphisms associated with prostate cancer in the Brazilian population.
Så RA; Moreira Ados S; Cabello PH; Ornellas AA; Costa EB; Matos Cda S; Alves G; Hatagima A
Int Braz J Urol; 2014; 40(4):463-73. PubMed ID: 25251951
[TBL] [Abstract][Full Text] [Related]
38. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
39. Association of XPC Gene Polymorphisms with Prostate Cancer Risk.
Kahnamouei SA; Narouie B; Sotoudeh M; Mollakouchekian MJ; Simforoosh N; Ziaee SA; Samzadeh M; Afshari M; Jamaldini SH; Imeni M; Hasanzad M
Clin Lab; 2016; 62(6):1009-15. PubMed ID: 27468562
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms of HOTAIR gene are associated with the risk of breast cancer in a sample of southeast Iranian population.
Hassanzarei S; Hashemi M; Sattarifard H; Hashemi SM; Bahari G; Ghavami S
Tumour Biol; 2017 Oct; 39(10):1010428317727539. PubMed ID: 29022495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
